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Abstract
Objectives: To evaluate the association of predicted lean and fat mass on 10-year first and recurrent CVD incidence
separately for men and women. Methods: Two prospective studies, ATTICA (2002-2012, n=3,042 subjects free-ofCVD, n=1,514 men (46±13 years) and n=1,528 women (45±14 years)) and GREECS (2004-2014, n=2,172 subjects
with acute coronary syndrome (ACS), n=1,649 men (65±13 years) and n=523 women (62±11 years)) were used. Lean
mass index (LMI) and fat mass index (FMI) were created through total body lean and fat mass (indirectly calculated
through population formulas based on body weight, height and waist circumference) divided by height squared.
Follow-up was performed in n=2,020 of ATTICA (n=317 first CVD events) and in n=2,172 patients of GREECS
(n=811 recurrent CVD events). Results: In ATTICA study, CVD rate from 1st to 3rd FMI tertile was 9.4%, 16.1% and
19.9% while in GREECS 36.2%, 37.0%, 38.3%. The LMI-related rates were 17.1%, 15.0% and 11.9% vs. 38.8%,
35.8% and 36.7%. Multiadjusted analysis revealed U-shape trend between LMI and CVD recurrence with 2nd LMI
tertile having the best prognosis; this observation was more evident in women. In apparently healthy subjects, LMIcardioprotective association was revealed only in 3rd tertile (HR= 0.91 95%CI (0.74, 0.95)); this was more evident in
men. The FMI aggravating association (3rd tertile) was retained significant only in healthy women and ACS men.
Conclusion: This work expands previous findings regarding body composition and cardiac health, implying that the
association of lean and fat mass on long-term CVD incidence varies according to sex and prevention stage.
Key words: heart disease; muscle mass; adiposity; gender

1. Introduction
Global overweight/obesity rates have reached epidemic levels. In 2016, more than 1.9 billion adults around the globe
were overweight while over 650 million were obese; interestingly, according to estimates for 2025 obesity prevalence,
women are to overlap men by five points (23% vs. 18% respectively) [1,2]. Abnormal weight has direct adverse effects
on CVD prevalence and severity. More discerning is that obesity independently increases the risk for almost all major
CVD risk factors and biological underpinnings such as insulin resistance, systemic inflammation and oxidative stress
[3]. Mechanisms through which abnormal weight status exerts its aggravating effect on cardiac health are correlated
with pathophysiological features attributed to the endocrine activity of adipose tissue [4].
In epidemiological research, weight status above the normal range and adiposity are mostly defined through
body mass index (BMI). Much as this marker presents a generally strong association with incident CVD, in muscleloss related conditions a reverse epidemiology (increased weight is associated with better prognosis) with not welldemonstrated underlying paths is observed [4-7]. Considering that fat-free mass is to have protective metabolic effects
in vascular system related with insulin resistance, oxidative stress and arterial stiffness, the aforementioned limitation
of BMI may result in erroneous assumptions regarding the actual prognosis of cardiac patients [8]. However, limited
evidence exists regarding the effect of body composition on cardiac patients’ prognosis and even less in apparently
healthy middle-aged subjects. Research to examine the effect of body composition on health outcomes have largely
been hampered due to practical issues. Body composition assessment on epidemiological studies requires sophisticated
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and expensive technologies. On the other hand, anthropometric measurements are simple, cheap and non-intrusive,
and hence are frequently measured in large health surveys and cohort studies. Towards this perspective, in a very
recent work from the the National Health and Nutrition Examination Survey (NHANES) 1999-2006, equations using
simple anthropometric measurements to evaluate lean and fat mass have been validated in a large diverse sample
showing an increased predictive ability against common CVD risk factors [9].
Hence, the aim of the present work was to apply the equations recently generated and validated by the
NHANES study to examine the association of predicted lean and fat mass on 10-year first and recurrent CVD
incidence. We performed two a priori research hypotheses; firstly, the inverse association of predicted lean mass,
highly supported in cardiac patients at advanced age, will be replicated for middle-aged apparently healthy subjects
as well and secondly, the anatomic, biological and lifestyle differences between men and women will result in sexmediated associations between body composition estimations and CVD onset or recurrence.

2. Subjects, Materials and Methods
2.1 Sample
To test the research hypothesis two, large-scale, cohort studies, i.e., the ATTICA and the GREECS, were
used.
The ATTICA study is a prospective, observational cohort investigation which was initiated in 2001 [10]. At
baseline (2001-2002), n=3,042 apparently healthy volunteers residing in the greater metropolitan Athens area, Greece,
agreed to participate (75% participation rate). Of the enrolled participants, n=1,514 (49.8%) were men (46±13 years)
and n=1,528 (50.2%) were women (45±14 years). All participants were free of CVD and other chronic diseases. For
the scope of the present work, we initially used the n=2,020 participants with complete CVD evaluation in the followup assessment.
The GREECS study is a prospective, observational cohort study, established in 2003 [11]. From October
2003 to September 2004, n=2,172 consecutive patients with discharge diagnosis of acute coronary syndrome (ACS)
(i.e., acute myocardial infarction (AMI) or unstable angina (UA)) hospitalized in the cardiology clinics of 6 major
General Hospitals in Greece were enrolled in the study (80-95% participation rate). Of the enrolled patients, n=1,649
(76%) were men (65±13) years) and n=523 (24%) were women (62±11 years).
2.2 Bioethics
The ATTICA study was approved by the Bioethics Committee of Athens Medical School and the GREECS
study was approved by the Medical Research Ethics Committee of the participated Institutions. Both studies were
carried out in accordance with the Declaration of Helsinki (1989) of the World Medical Association. All participants
were informed about the aims and procedures of the study and signed an informed consent.
2.3 Weight status and body composition estimation
In both studies, weight status was defined using BMI World Health Organization cut off points. BMI was
calculated as weight (in kilograms) divided by height (in meters squared). Height was measured to the nearest 0.5 cm,
with participants not wearing shoes, their backs square against the measuring wall tape, eyes looking straight ahead,
with a right‐angled triangle resting on the scalp and against the wall. Weight was measured with a lever balance, to
the nearest 100 grams, without shoes and in light undergarments. Normal weight was defined as BMI between 18.5
and 25 kg/m2, overweight as BMI between 25 and 29.9 kg/m2 and obesity as BMI≥30 kg/m2. Underweight was defined
as BMI <18.5 kg/m2.
Due to the lack of imaging data for body composition i.e. lean and fat mass (kg), sex-specific populationbased equations were used to predict body composition, recently validated by the investigators of the NHANES study
[9]. For the ATTICA participants, we used the equations adjusted for weight, height and waist circumference, since
these were suggested to have the best predictive and discrimination ability against CVD risk factors. For the GREECS
study, because of the lack of waist circumference measurements, lean and fat mass were calculated based on weightand height- adjusted equations. The population-based equations used here can be found elsewhere [9]. Then, we
standardized the generated body composition estimations for lean and fat mass (kg) through dividing by height (in
meters squared), to create lean mass index (LMI) and fat mass index (FMI) (kg/m2); increased values in these indexes
corresponded to increased lean and fat mass, respectively. Participants were separated according to sex-specific LMI
and FMI tertiles.
Further details about aims, measurements and baseline procedures of ATTICA and GREECS studies can be
found elsewhere [10,11].
2.4 Endpoints and follow-up
The combined endpoint studied in this work was the development of a fatal or non-fatal CVD event during the 10year follow-up; specifically, a first event, for the ATTICA study (2012) participants and recurrent event, for the
GREECS study (2014) ACS patients. A CVD event was defined as the development of acute myocardial infarction,
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or unstable angina, or other identified forms of ischemia (WHO-ICD coding 410–414.9, 427.2, 427.6), or heart failure
of different types and chronic arrhythmias (WHO-ICD coding 400.0–404.9, 427.0–427.5, 427.9) or stroke (WHOICD coding 430–438). For participants who died during follow-up, information was retrieved from relatives and death
certificates.
2.5 Statistical analysis
Categorical variables are presented as absolute (n) and relative frequencies (%). Continuous variables are presented
as mean values ± standard deviation or median (Interquartile Range) if normality was not met. Associations between
normally distributed variables and CVD event status were evaluated through Student’s t-test for independent samples.
Whether these variables were normally distributed was tested through P-P plot and equality of variances through
Levene’s test. For non-normally distributed variables, Mann-Whitney test was used. Associations between categorical
variables and CVD event status was tested with the chi-squared test. Hazard Ratios (HR) and their corresponding 95%
Confidence Intervals (95%CI) were evaluated through multivariable Cox-regression analysis; Cox regression analysis
was implemented through the construction of nested models (each model is a subset of another model) starting from
a crude model (i.e., Model 1) and resulting in a fully adjusted model (i.e., Model 5) [12]. In particular,
sociodemographic (i.e., age, sex, educational status), lifestyle (i.e., physical activity, smoking status, adherence to
Mediterranean diet) and clinical factors (i.e., family and individual history of CVD, discharge status, diabetes,
hypercholesterolemia and hypertension, inflammation) were taken into account as potential confounders of the
examined association. Multicollinearity was checked through the Variance Inflation Factor. A-posteriori statistical
power analysis revealed that the recruited sample as well as man and woman subsamples in the ATTICA study were
adequate to achieve power equal or higher to 75% for testing two-sided hypothesis of HR equal to 0.80 at 5%
significance level, whereas, the relevant statistical power achieved in the GREECS study was 0.95%. The concordance
statistics, i.e., C-statistic, was used to evaluate the predictive accuracy of multivariate models adjusted for various
lipid markers against CVD event. C-indexes and the corresponding 95%CIs were equal to the areas under the curve
obtained from ROC analysis. Curves were constructed by plotting sensitivity against (1-specifity). Significance of the
changes in C-index was tested by differences in 2 log likelihood of regression models with and without anthropometric
measurements. Level of significance was set at two-sided p-value<5%. The STATA software, version 14 (MP &
Associates, Sparta, Greece) was used for all statistical analyses.

3. Results
The baseline characteristics of ATTICA and GREECS men and women participants according to their 10-year CVDincidence and BMI status can be found in supplementary file.
In Table 1 10-year CVD event rates are presented separately, in apparently healthy individuals (ATTICA
study) and in ACS patients (GREECS study), overall, as well as according to BMI and body composition estimations.
Apparently healthy men with FMI in 3rd tertile were about 3 times more likely to suffer from a cardiac episode with a
similar trend observed in women. As for ACS patients, women in the 2nd FMI tertile exhibited the lowest CVD
recurrence rate with men of the same tertile having about 45% higher likelihood to suffer from a new episode. In the
ATTICA sample, men with low LMI were about 2.38 times more likely to develop CVD compared with women of
the same tertile. When it came to 2nd and 3rd tertile the consistent exceeding of men on CVD event rate over women
was significantly alleviated. In the patients sample of GREECS study, different trends were observed with women in
the 2nd LMI tertile presenting the best ACS prognosis revealing a U-shape trend which was not retained in case of
their men counterparts. In the ATTICA sample, even in high FMI men with LMI within the 3 rd tertile had closer-towomen 10-year CVD event rate (i.e. 1.49). As for the ACS patients, even if in the overall sample men’s and women’s
CVD recurrence rate was quite similar in the context of high lean yet low fat mass, women presented even better ACS
prognosis.
[Table 1]
Nested Cox regression models to evaluate the role of BMI and body composition estimations on 10-year first
CVD event rate are presented in Table 2. In the fully adjusted model, obesity as well as FMI in the 3rd tertile were
associated with about 40% higher CVD risk compared with their reference groups. As for the lean mass, participants
with the highest LMI had about 10% lower risk to develop a cardiac episode within the decade (p<0.05). When the
combined effect of lean and fat mass was examined, participants with high fat and low lean mass presented the highest
CVD risk compared with the reference group (i.e. low lean and low fat mass) (HR=2.50 95%CI (1.26, 4.40)) while
this trend was alleviated in the context of high fat yet high lean mass (HR=1.68 95%CI (1.15, 2.44)).
[Table 2]
Nested Cox regression models were constructed to evaluate the role of BMI and body composition
estimations on recurrent CVD event rate and presented in Table 3. Focusing on BMI, in the fully adjusted model a Ushape trend was observed with overweight patients having about 50% lower risk to suffer from a new cardiac episode
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over their normalweight counterparts (p<0.05). As for FMI, even if unadjusted model revealed a significantly
increased risk in patients within the 3rd FMI tertile, this trend was lost in the fully adjusted model. Focusing on lean
mass, patients in 2nd LMI tertile had about 30% lower risk for CVD recurrence yet higher LMI did not reach the level
of significance. In the analysis with the combined effect of lean and fat mass, participants with low fat and high lean
mass presented the lowest CVD risk compared with the reference group (i.e. low lean and low fat mass) (HR=0.61
95%CI (0.38, 0.95)). The protective role of lean mass was lost in the context of high fat mass (HR=1.57 95%CI (1.04,
2.17)) even if it seemed to provide a prognostic advantage compared with the respective HR for patients with high fat
yet low lean mass (HR=2.19 95%CI (1.17, 3.05)).
[Table 3]
In the formal analysis of interaction, significant heterogeneities were produced in relation to sex and body
weight or body composition estimations in both ATTICA and GREECS study (all ps for sex interaction<0.10).
Thereby, stratified analyses were performed using sex as strata and the respective results are presented in Table 4.
Obesity was independently associated with first CVD event only in men (HR=1.85 95%CI (1.28, 3.68)) while
FMI within the 3rd tertile range only in women (HR=1.66 95%CI (1.05, 2.62)). Men in 3rd LMI tertile were protected
against CVD onset (HR=0.77 95%CI (0.58, 0.89)); this trend was retained in women yet without being significant.
Men with high fat yet low lean mass had significantly higher CVD risk compared with the reference group (HR=2.91
95%CI (1.81, 4.44)). In the context of high fat mass yet LMI on the 3rd tertile the aforementioned high CVD risk was
retained significant only in women.
Obesity was independently associated with recurrent CVD event only in men (HR=1.82 95%CI (1.00, 2.94)).
Overweight women were protected against CVD recurrence (HR=0.47 95%CI (0.29, 0.92)). As for FMI, only men in
the 3rd tertile had increased CVD risk (HR=1.75 95%CI (1.10, 2.10)). In women patients, a U-shape LMI-related trend
was observed with those in the 2nd tertile having 40% lower risk to develop a new cardiac episode. Both men and
women with high fat yet low lean mass had significantly higher CVD risk compared with the reference group.
However, in the context of high fat mass yet LMI on the 3rd tertile the aforementioned high CVD risk was retained
significant only in men. Lastly, a status with high lean yet low fat mass was protective for both sexes.
[Table 4]
The discrimination ability of epidemiological models adjusted for BMI or body composition estimations was
evaluated separately for men and women and results are presented in Table 5. Overall, the discrimination ability
(expressed through C-index) of the examined models was better in ATTICA study sample. In men, both FMI and LMI
significantly contributed to principle endpoint yet with the result being more evident for LMI (p for C-index
difference=0.001). As for women, only FMI-adjusted model had an added discrimination ability (p for C-index
difference=0.003). As for the results corresponding to GREECS study, in men, FMI seemed to significantly increase
the base-model discrimination ability against CVD recurrence (p for C-index difference=0.04) while in women
patients, LMI-adjusted model discriminated better the primary endpoint (p for C-index difference=0.002).
[Table 5]

4. Discussion
In the present work, we identified that the association of predicted lean and fat mass, generated from population-based
equations, on long-term CVD incidence may vary according to sex as well as according to CVD prevention stage. In
line with our initial hypothesis, it was revealed that lean mass may have an independent cardioprotective role not only
in patients with established CVD and advanced age, but also in apparently healthy middle-aged individuals.
Interestingly, sex-specific remarks were highlighted. In particular, LMI seemed to independently protect against CVD
even in the context of increased weight status or adiposity in male free-of-CVD subjects. In case of female ACS
patients it is noteworthy that the same association followed a U-shape trend. On the other side, FMI seemed to
significantly aggravate cardiac health in free-of-CVD women as well as in men with established disease.
Lean mass as a novel prognostic factor is attracting considerable attention in patients with established CVD
[13]. Our work sets implications that high lean mass accompanied by obese and/or excess-body-fat status may not be
that protective which comes in line with previous studies [8,14,15]. Much as adipose tissue as endocrine organ presents
a bidirectional communication with vascular system, in established diseases like CVD, this homeostasis-related
condition is lost; with dysfunctional and harmful cell–cell and tissue–tissue interactions between adipose tissue and
cardiac system [16,17]. The present work is one of the very first that investigated sex differences in the association
between body composition estimations and recurrent CVD event. Sensitivity analysis, revealed that women in 2nd LMI
tertile presented the best prognosis compared with 1 st and 3rd LMI tertile while this trend was not confirmed in men.
This comes in line with a very recent work from a Greek sample [18]. There are indications that women in advanced
age [19] and/or with an established catabolic disease [20] may be more vulnerable in lean mass loss compared with
men of similar age and disease profile probably due to lifestyle or biological factors [21,22]. Additionally, what is
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highly suggested for women patients, is a more pronounced BMI-related paradoxical association, also confirmed here
[23]. This has been attributed greater myocardial fatty acid uptake and lower myocardial utilization in women [24].
The added value of our work is related with highlights that women’s “overweight paradox” may be attributed not only
to their resistance to adiposity but also to sex-specific responses of lean mass. We revealed that ACS women patients
with moderate LMI presented the best prognosis; this patients category was mostly overweight and/or with low to
medium total fat mass (data not presented on tables). On the other side, further raise in FMI, probably accompanied
by visceral adiposity considering the life stage of women participants, attenuated the potential protective effect of lean
mass which has been observed elsewhere [25].
Body composition in apparently healthy younger individuals has been scarcely studied. In the present work,
we show that BMI and FMI presented an independently positive association with CVD incidence only under the
context of highest adiposity rates. On the other side, LMI had a protective effect against CVD. Examining the
combined role of FMI and LMI on CVD onset, FMI remained an independent risk factor even in high LMI values yet
with lower effect size compared with lower LMI. This independent association of FMI comes in line with a very recent
big data analysis (UK Biobank) [26]; yet the added value of our work was the consideration of lean mass on this
association which has mostly been applied in patient or at-advance-age populations. Our sex-stratified analysis
revealed that the aforementioned associations were retained only in women; while in men LMI had a stronger
protective effect against CVD even in the context of high adiposity estimations. These indications are partially aligned
with previous works. Sex-specific analysis in UK Biobank revealed that adiposity metrics had a stronger aggravating
for women compared with men [27]. In the PREVEND cohort study, adiposity was independently associated with
CVD onset even after adjusting for a muscle mass indicator with marginally stronger association in women, yet only
on the basis of total fat mass [26]. Different fat distribution between sexes may partially explain these observations.
To this issue, there are indications that total body fat may have a higher predictive ability in women whereas in men
focus should be oriented towards visceral adiposity metrics [28]. Additionally, sex is to influence adipocyte size in
specific anatomic regions. Given the same weight gain, intraperitoneal visceral adipocyte size in men marginally
increases compared with the rise in women; large adipocytes are associated with more proinflammatory hormonemediated adipokine secretion which may explain the susceptibility of women in excess body fat [29-31]. Moreover,
the observed association may be gene-mediated; in Women’s Genome Health study it was revealed that a fat-mass
related gene had an independent aggravating effect on women’s CVD risk especially in those with low physical
activity [32]. Finally, several hypotheses could be performed regarding the protective effect of lean mass against
excess adiposity only in men. Firstly, physiologically middle-aged men have higher lean mass compared with women.
Secondly, within younger ages men present a higher level of physical activity compared with women which may affect
their lean mass on the basis of quantity, metabolic activity and strength [33]. Thirdly, in our study, men with high LMI
had significantly lower waist circumference compared with their counterparts in lower LMI tertiles (descriptive data
not presented on tables) which could have driven the final outcome. Lastly, this observation may be mediated by
testosterone levels. Lean mass is highly correlated with testosterone levels. Hence, behind the lower lean mass metrics,
testosterone deficiency may be hindered; considering the mounting evidence suggesting that normal testosterone
levels are beneficial to men’s vascular system and that testosterone deficiency is associated with an unfavorable
metabolic profile, including increased adiposity and insulin resistance, the findings of the present work may be
attributed to this intermediate path [34].
4.1 Limitations and strengths
The main strength here that compensates any limitations is that this in one of the very few works that evaluated the
association of predicted body composition metrics in terms of fat yet most importantly lean mass on long-term CVD
event providing sex- and CVD-prevention-stage specific remarks which are scarce in the hitherto literature [35-37].
The principle limitation is related with the estimation of body composition metrics through population-based equations
and not imaging or skinfold data; this is anticipated by the fact that we used equations validated through imaging
(DXA-measured) data separately for men and women. Additionally, these equations are not validated for the Greek
sample; however, a. they have been validated in the context of a large-scale epidemiological study with diverse,
nationwide sample [9] and b. they have been applied in the present work using objective metrics and not self-reported
data which could have biased the final outcome [38].
4.2 Conclusion
Major tailor-made recommendations remain to be guided for the actual predictive and prognostic ability of
body composition parameters on daily clinical practice. Even if the methodological and sample-related limitations of
the present work do not allow the generalization of the principle conclusions, considering the limited evidence,
especially in younger, free-of-disease individuals, our work comes to expand knowledge towards this approach.
Firstly, outcomes here suggest that preserving healthy lean mass and deterring muscle loss not only in cardiac
rehabilitation programs but also in preventive medicine initiatives should be enhanced. Subsequently, excess adiposity
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had clear adverse effects on cardiac health; even if preservation of quantity and strength of lean mass may alleviate
this claim, constant vigilance is needed to achieve healthy weight maintenance through balanced diet and adherence
to an active lifestyle. Lastly, the sex-specific remarks revealed here set the basis for better identifying the particular
anthropometric features that affects men’s and women’s cardiac health.

References
[1]

[2]
[3]

[4]
[5]

[6]

[7]

[8]
[9]

[10]

[11]

[12]
[13]

[14]

[15]

[16]
[17]

[18]

NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to
2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet
2016;387:1377-1396. https://doi.org/10.1016/S0140-6736(16)30054-X
World Health Organization (WHO). Noncommunicable diseases country profiles 2018. Geneva: WHO; 2018.
Licence: CC BY-NC-SA 3.0 IGO.
Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy Weight and Obesity Prevention:
JACC
Health
Promotion
Series.
J
Am
Coll
Cardiol
2018;72:1506-1531.
https://doi.org/10.1016/j.jacc.2018.08.1037
Ortega-Loubon C, Fernández-Molina M, Singh G, Correa R. Obesity and its cardiovascular effects. Diabetes
Metab Res Rev 2019;35:e3135. https://doi.org/10.1002/dmrr.3135.
Kastorini CM, Panagiotakos DB. The obesity paradox: methodological considerations based on epidemiological
and
clinical
evidence--new
insights.
Maturitas
2012;72:220-224.
https://doi.org/10.1016/j.maturitas.2012.04.012
Goel K, Thomas RJ, Squires RW, et al. Combined effect of cardiorespiratory fitness and adiposity on mortality
in
patients
with
coronary
artery
disease.
Am
Heart
J
2011;161:590-597.
https://doi.org/10.1016/j.ahj.2010.12.012.
Gastelurrutia P, Pascual-Figal D, Vazquez R, et al. Obesity paradox and risk of sudden death in heart failure
results from the MUerte Subita en Insuficiencia cardiaca (MUSIC) study. Am Heart J 2011;161:158-164.
https://doi.org/10.1016/j.ahj.2010.10.018.
Srikanthan P, Horwich TB, Tseng CH. Relation of Muscle Mass and Fat Mass to Cardiovascular Disease
Mortality. Am J Cardiol 2016;117:1355-1360. https://doi.org/10.1016/j.amjcard.2016.01.033.
Lee DH, Keum N, Hu FB, et al. Development and validation of anthropometric prediction equations for lean
body mass, fat mass and percent fat in adults using the National Health and Nutrition Examination Survey
(NHANES) 1999-2006. Br J Nutr 2017;118:858-866. https://doi.org/10.1017/S0007114517002665.
Pitsavos C, Panagiotakos DB, Chrysohoou, Stefanadis C. Epidemiology of cardiovascular risk factors in
Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 2003;3:32.
https://doi.org/10.1186/1471-2458-3-32.
Pitsavos C, Panagiotakos DB, Antonoulas A, et al; Greek study of acute Coronary Syndromes study
investigators. Epidemiology of acute coronary syndromes in a Mediterranean country; aims, design and baseline
characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health 2005;5:23.
https://doi.org/10.1186/1471-2458-5-23.
Kohler, U., Karlson, K.B., Holm, A. Comparing coefficients of nested nonlinear probability models. The Stata
Journal 2011;11:420-438.
Mok M, Allende R, Leipsic J, et al. Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by
Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation. Am J Cardiol
2016;117:828-933. https:// doi.org/10.1016/j.amjcard.2015.12.015.
Medina-Inojosa JR, Somers VK, Thomas RJ, et al. Association Between Adiposity and Lean Mass With LongTerm Cardiovascular Events in Patients With Coronary Artery Disease: No Paradox. J Am Heart Assoc
2018;7:e007505. https://doi.org/10.1161/JAHA.117.00750.
Spahillari A, Mukamal KJ, DeFilippi C, et al. The association of lean and fat mass with all-cause mortality in
older adults: The Cardiovascular Health Study. Nutr Metab Cardiovasc Dis 2016;26:1039-1047.
https://doi.org/10.1016/j.numecd.2016.06.011.
Antoniades C. 'Dysfunctional' adipose tissue in cardiovascular disease: a reprogrammable target or an innocent
bystander? Cardiovasc Res 2017;113:997-998. https://doi.org/10.1093/cvr/cvx116.
Wu G, Li H, Zhou M, et al. Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding
protein linking obesity and atherosclerosis. Diabetes Metab Res Rev 2014;30:447-456.
https://doi.org/10.1002/dmrr.2493.
Kouvari M, Chrysohoou C, Dilaveris P, et al. Skeletal muscle mass in acute coronary syndrome prognosis:
Gender-based analysis from Hellenic Heart Failure cohort. Nutr Metab Cardiovasc Dis. 2019;29:718-727.
https://doi.org/10.1016/j.numecd.2019.03.011.

6

[19] Yang L, Smith L, Hamer M. Gender-specific risk factors for incident sarcopenia: 8-year follow-up of the
English longitudinal study of ageing. J Epidemiol Community Health 2018; epud ahead of print 27 October
2018; https://doi.org/10.1136/jech-2018-211258.
[20] Anderson LJ, Liu H, Garcia JM. Sex Differences in Muscle Wasting. Adv Exp Med Biol 2017;1043:153-197.
https://doi.org/10.1007/978-3-319-70178-3_9.
[21] Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L. The Heart Failure Overweight/Obesity Survival Paradox:
The Missing Sex Link. J Am Coll Cardiol HF 2015;3:917-926. https://doi.org/10.1016/j.jchf.2015.06.009.
[22] Kouvari M, Panagiotakos DB, Chrysohoou C, et al. Gender-specific, Lifestyle-related Factors and 10-year
Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies. Curr Vasc Pharmacol 2018; epud
ahead of print 8 June 2018; https://doi.org/10.2174/1570161116666180608121720.
[23] Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk
of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc
2014;62:253-260. https://doi.org/10.1111/jgs.12857.
[24] Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, Mohamed A, Davenport A. Differences in the
prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity. J Hum Nutr Diet
2018;31:689-696. https://doi.org/10.1111/jhn.12555.
[25] Dereziński T, Zozulińska-Ziółkiewicz D, Uruska A, Dąbrowski M. Visceral adiposity index as a useful tool for
the assessment of cardiometabolic disease risk in women aged 65 to 74. Diabetes Metab Res Rev
2018;34:e3052. https://doi.org/10.1002/dmrr.3052.
[26] Iliodromiti S, Celis-Morales CA, Lyall DM, et al. The impact of confounding on the associations of different
adiposity measures with the incidence of cardiovascular disease: a cohort study of 296 535 adults of white
European descent. Eur Heart J 2018;39:1514-1520. https://doi.org/10.1093/eurheartj/ehy057.
[27] Byambasukh O, Eisenga MF, Gansevoort RT, Bakker SJ, Corpeleijn E. Body fat estimates from bioelectrical
impedance equations in cardiovascular risk assessment: The PREVEND cohort study. Eur J Prev Cardiol
2019:2047487319833283. https://doi.org/10.1177/2047487319833283.
[28] Onat A, Ug˘ ur M, Can G, Yüksel H, Hergenç G. Visceral adipose tissue and body fat mass: Predictive values
for and role of gender in cardiometabolic risk among Turks. Nutrition 2010;26: 382–389.
https://doi.org/10.1016/j.nut.2009.05.019.
[29] Stefanska A, Bergmann K, Sypniewska G. Metabolic Syndrome and Menopause: Pathophysiology, Clinical
and Diagnostic Significance. Adv Clin Chem 2015;72:1-75. https://doi.org/10.1016/bs.acc.2015.07.001.
[30] Lee SH, Tak YJ, Yi YH, et al. Correlations between obesity indices and cardiometabolic risk factors in obese
subgroups in women with severe obesity: A multicenter, cross-sectional study. Obes Res Clin Pract.
2017;11:167-176. https://doi.org/10.1016/j.orcp.2016.03.014.
[31] Hung SP, Chen CY, Guo FR, Chang CI, Jan CF. Combine body mass index and body fat percentage measures
to improve the accuracy of obesity screening in young adults. Obes Res Clin Pract. 2017;11:11-18.
https://doi.org/10.1016/j.orcp.2016.02.005.
[32] Ahmad T, Chasman DI, Mora S, et al. The fat-mass and obesity-associated (FTO) gene, physical activity, and
risk of incident cardiovascular events in white women. Am Heart J 2010;160:1163-1169.
https://doi.org/10.1016/j.ahj.2010.08.002.
[33] Shiroma EJ, Lee IM. Physical activity and cardiovascular health: lessons learned from epidemiological studies
across
age,
gender,
and
race/ethnicity.
Circulation
2010;122:
743-752.
https://doi.org/10.1161/CIRCULATIONAHA.109.914721.
[34] Elagizi A, Köhler TS, Lavie CJ. Testosterone and Cardiovascular Health. Mayo Clin Proc 2018;93:83-100.
https://doi.org/10.1016/j.mayocp.2017.11.006.
[35] Furer A, Afek A, Orr O, et al. Sex-specific associations between adolescent categories of BMI with
cardiovascular and non-cardiovascular mortality in midlife. Cardiovasc Diabetol 2018;17:80.
https://doi.org/10.1186/s12933-018-0727-7.
[36] Baker JL, Olsen LW, Sørensen TI. Childhood body-mass index and the risk of coronary heart disease in
adulthood. N Engl J Med 2007;357:2329-2337.
[37] Twig G, Yaniv G, Levine H, et ak. Body-Mass Index in 2.3 Million Adolescents and Cardiovascular Death in
Adulthood. N Engl J Med 2016;374:2430-2440. https://doi.org/10.1056/NEJMoa1503840.
[38] Keith SW, Fontaine KR, Pajewski NM, Mehta T, Allison DB. Use of self-reported height and weight biases
the
body
mass
index-mortality
association.
Int
J
Obes
(Lond)
2011;35:401-408.
https://doi.org/10.1038/ijo.2010.148.

7

Table 1 Unadjusted cardiovascular disease incidence rate in men and women from the ATTICA and GREECS study according to their body mass and body composition
indexes.
ATTICA study (Outcome: First fatal/non fatal CVD event)
CVD incidence rate
per 100 participants

Men-to-women
CVD incidence rate ratio

Total sample

Men

Women

n=2,020

n=1,005

n=1,015

15.7

19.7

11.7

1.66

Normal weight
9.6
Overweight
18.6
Obese
23.6
Body fat mass index tertiles
1st
9.4
2nd
16.1
3rd
19.9
Body lean mass index tertiles
1st
17.1
2nd
15.0
3rd
11.9
Body fat and lean mass status
Low lean/low fat mass
9.9
High lean/low fat mass
8.4
Low lean/high fat mass
27.9
High lean/high fat mass
15.7
GREECS study (Outcome: Recurrent fatal/non fatal CVD event)

14.4
20.2
26.0

7.2
15.8
20.6

2.00
1.27
1.26

13.8
21.1
19.9

5.2
11.0
16.3

2.65
1.91
1.02

23.8
16.9
18.3

12.0
13.0
9.7

2.38
1.30
1.88

15.1
20.2
11.9
19.0

5.7
6.9
19.2
12.7

2.64
2.92
1.75
1.49

CVD incidence rate
per 100 participants

Total sample

Men

Women

Men-to-women
CVD incidence rate ratio

n=2,172

n=1,649

n=523

Overall
BMI categories

37.3

38.8

32.9

1.17

Normalweight
Overweight
Obese
Body fat mass index tertiles
1st
2nd

36.7
35.8
38.0

38.7
39.2
37.2

33.8
26.9
35.2

1.14
1.45
1.05

36.2
38.0

37.5
38.9

33.1
27.6

1.13
1.40

Overall
BMI categories

8

3rd

37.3

39.6

36.4

1.08

1st
2nd
3rd

38.8
35.8
36.7

39.5
40.2
36.2

34.0
28.5
34.7

1.16
1.41
1.04

Body fat and lean mass status
Low lean/low fat mass
High lean/low fat mass
Low lean/high fat mass
High lean/high fat mass

37.5
41.8
31.0
36.5

39.7
44.6
32.8
36.7

30.8
44.4
23.5
35.9

1.28
1.01
1.39
1.02

Body lean mass index tertiles

Unadjusted 10-year CVD rates were obtained through chi-squared test. Body fat mass index (FMI) was created to reflect total body fat mass and body lean mass index (LMI) to reflect total body lean mass (indirectly calculated through population
formulas); high fat mass corresponded to 3rd FMI sex-specific tertile and high lean mass corresponded to 3rd LMI sex-specific tertile while low fat mass corresponded to 1st merged with 2nd FMI sex-specific tertile and low lean mass corresponded to 1st
merged with 2nd LMI sex-specific tertile. Abbreviations: Cardiovascular disease (CVD)
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Table 2 Multi-adjusted analysis to evaluate the association between body composition status and 10-year cardiovascular disease incidence in apparently healthy
individuals of the ATTICA study (n=2,020).
Model 1
Model 2
Model 3
Model 4
HR (95%CI)
HR (95%CI)
HR (95%CI)
HR (95%CI)
Model for body mass index
Normalweight
Ref
Ref
Ref
Ref
Overweight
0.91 (0.57, 1.44)
0.80 (0.48, 1.31)
2.17 (1.63, 2.91)
1.27 (1.00, 1.77)
Obese
2.94 (2.11, 4.11)
1.69 (1.16, 2.44)
1.44 (1.05, 2.27)
1.41 (1.00, 2.20)
Model for body fat mass index
1st
Ref
Ref
Ref
Ref
2nd
1.14 (0.77, 1.69)
0.83 (0.49, 1.41)
0.75 (0.42, 1.30)
1.81 (1.27, 2.58)
3rd
3.20 (2.29, 4.47)
1.55 (1.17, 2.35)
1.45 (1.10, 2.18)
1.39 (1.04, 2.12)
Model for body lean mass index
1st
Ref
Ref
Ref
Ref
2nd
0.96 (0.52, 1.07)
1.05 (0.67, 1.22)
1.09 (0.75, 1.35)
0.81 (0.40, 0.92)
3rd
0.65 (0.31, 0.75)
0.83 (0.64, 0.91)
0.89 (0.71, 0.93)
0.91 (0.74, 0.95)
Model for body fat and lean mass
status
Low lean/low fat mass
Ref
Ref
Ref
Ref
High lean/low fat mass
0.62 (0.22, 0.73)
0.79 (0.27, 0.86)
0.82 (0.46, 0.97)
0.82 (0.46, 0.97)
Low lean/high fat mass
3.02 (2.14, 4.80)
2.71 (1.33, 4.66)
2.50 (1.26, 4.40)
2.50 (1.26, 4.40)
High lean/high fat mass
1.97 (1.35, 2.69)
1.82 (1.28, 2.52)
1.68 (1.15, 2.44)
1.68 (1.15, 2.44)
HRs and their corresponding 95%CIs were obtained from Cox regression analysis; Model 1: crude model; Model 2: age and sex; Model 3: Model 2 plus current smoking, hypertension, diabetes mellitus, MedDietScore, physical activity status,
years of school, family history of cardiovascular disease; Model 4: Model 3 plus C-reactive protein, alanine transaminase, aspartate transaminase, creatinine clearance. Body fat mass index (FMI) was created to reflect total body fat mass and
body lean mass index (LMI) to reflect total body lean mass (indirectly calculated through population formulas); high fat mass corresponded to 3rd FMI sex-specific tertile and high lean mass corresponded to 3rd LMI sex-specific tertile while
low fat mass corresponded to 1st merged with 2nd FMI sex-specific tertile and low lean mass corresponded to 1st merged with 2nd LMI sex-specific tertile. Abbreviations: Hazard Ratio (HR), 95% Confidence Interval (95%CI). Bold indicates
statistically significant outcomes i.e. p<0.05
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Table 3 Multi-adjusted analysis to evaluate the association between body composition status and 10-year cardiovascular disease incidence in patients with established
Acute Coronary Syndrome of the GREECS study (n=2,172).
Model 1
Model 2
Model 3
Model 4
HR (95%CI)
HR (95%CI)
HR (95%CI)
HR (95%CI)
Model for body mass index
Normalweight
Ref
Ref
Ref
Ref
Overweight
0.34 (0.22, 0.78)
0.48 (0.36, 0.89)
0.55 (0.33, 0.97)
0.55 (0.33, 0.97)
Obese
2.01 (0.96, 2.89)
1.77 (0.95, 2.78)
1.78 (0.95, 2.76)
2.53 (1.41, 3.41)
Model for body fat mass index
1st
Ref
Ref
Ref
Ref
2nd
1.08 (0.72, 1.20)
1.09 (0.72, 1.23)
0.89 (0.41, 0.94)
0.94 (0.50, 0.99)
3rd
2.15 (1.12, 3.05)
1.67 (0.92, 2.20)
2.04 (1.10, 2.79)
1.85 (1.03, 2.48)
Model for body lean mass index
1st
Ref
Ref
Ref
Ref
2nd
0.63 (0.41, 0.96)
0.68 (0.46, 0.94)
0.69 (0.46, 0.95)
0.77 (0.58, 0.98)
3rd
1.31 (0.85, 2.02)
1.28 (0.82, 2.01)
1.30 (0.73, 2.29)
1.19 (0.69, 2.10)
Model for body fat and lean mass
status
Low lean/low fat mass
Ref
Ref
Ref
Ref
High lean/low fat mass
0.41 (0.11, 0.65)
0.56 (0.25, 0.79)
0.60 (0.38, 0.94)
0.61 (0.38, 0.95)
Low lean/high fat mass
2.43 (1.34, 3.80)
2.23 (1.20, 3.47)
2.18 (1.15, 3.10)
2.19 (1.17, 3.05)
High lean/high fat mass
1.85 (1.24, 2.67)
1.64 (1.18, 2.32)
1.57 (1.05, 2.16)
1.57 (1.04, 2.17)
HRs and their corresponding 95%CIs were obtained from Cox regression analysis; Model 1: crude model; Model 2: age and sex; Model 3: Model 2 plus current smoking, hypertension, diabetes mellitus, MedDietScore, physical activity
status, years of school, family history of cardiovascular disease; Model 4: Model 3 plus baseline cardiovascular disease history, discharge status (i.e. acute myocardial infarction or unstable angina at baseline) and adherence to medication.
Body fat mass index (FMI) was created to reflect total body fat mass and body lean mass index (LMI) to reflect total body lean mass (indirectly calculated through population formulas); high fat mass corresponded to 3 rd FMI sex-specific
tertile and high lean mass corresponded to 3rd LMI sex-specific tertile while low fat mass corresponded to 1 st merged with 2nd FMI sex-specific tertile and low lean mass corresponded to 1st merged with 2nd LMI sex-specific tertile.
Abbreviations: Hazard Ratio (HR), 95% Confidence Interval (95%CI). Bold indicates statistically significant outcomes i.e. p<0.05
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Table 4 Sex-based stratified multivariate analysis to evaluate the association between body composition status and 10-year cardiovascular disease incidence in
men and women of the ATTICA (n=2,020) and GREECS study (n=2,172).
ATTICA study (Outcome: First fatal/non fatal cardiovascular disease event)

Model for body mass index
Normalweight
Overweight
Obese
p for interaction=0.07
Model for body fat mass index
1st
2nd
3rd
p for interaction=0.01
Model for body lean mass index
1st
2nd
3rd
p for interaction=0.04
Model for body fat and lean mass
status
Low lean/low fat mass
High lean/low fat mass
Low lean/high fat mass
High lean/high fat mass
p for interaction=0.08

Men
HR (95%CI)

Women
HR (95%CI)

Ref
1.04 (0.57, 1.88)
1.85 (1.28, 3.68)

Ref
0.76 (0.35, 1.65)
1.10 (0.59, 2.47)

Ref
0.82 (0.41, 1.63)
1.24 (0.64, 2.39)

Ref
1.32 (0.82, 2.13)
1.66 (1.05, 2.62)

Ref
0.96 (0.84, 1.17)
0.77 (0.58, 0.89)

Ref
1.10 (0.62, 1.27)
0.95 (0.81, 1.13)

Ref
0.75 (0.37, 0.95)
2.91 (1.81, 4.44)
1.31 (0.81, 2.10)

Ref
0.61 (0.23, 2.16)
2.83 (1.65, 4.84)
2.41 (1.28, 4.53)

GREECS study (Outcome: Recurrent fatal/non fatal cardiovascular disease event)

Model for body mass index
Normalweight
Overweight
Obese
p for interaction=0.01
Model for body fat mass index

Men
HR (95%CI)

Women
HR (95%CI)

Ref
0.65 (0.40, 1.10)
1.82 (1.00, 2.94)

Ref
0.47 (0.29, 0.92)
1.64 (0.90, 2.66)
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1st
2nd
3rd

Ref
1.12 (0.75, 1.25)
1.75 (1.10, 2.10)

Ref
0.95 (0.61, 1.11)
1.46 (0.85, 1.89)

1st
2nd
3rd

Ref
0.84 (0.38, 1.10)
1.85 (0.82, 2.38)

Ref
0.63 (0.31, 0.99)
0.91 (0.36, 2.30)

Ref
0.75 (0.55, 0.99)
2.41 (1.36, 3.24)
1.64 (1.18, 2.25)

Ref
0.44 (0.20, 0.87)
1.87 (1.10, 2.79)
1.42 (0.90, 1.99)

p for interaction =0.05
Model for body lean mass index

p for interaction=0.02
Model for body fat and lean mass
status
Low lean/low fat mass
High lean/low fat mass
Low lean/high fat mass
High lean/high fat mass
p for interaction=0.02

HRs and their corresponding 95%CIs were obtained from Cox regression analysis; for ATTICA study, model was adjusted for: age, current smoking, hypertension, diabetes mellitus, MedDietScore, physical activity status, years
of school, family history of cardiovascular disease, C-reactive protein, alanine transaminase, aspartate transaminase, creatinine clearance / for GREECS study, model was adjusted for age, current smoking, hypertension, diabetes
mellitus, MedDietScore, physical activity status, years of school, family history of cardiovascular disease, baseline cardiovascular disease history, discharge status (i.e. acute myocardial infarction or unstable angina at baseline)
and adherence to medication. Body fat mass index (FMI) was created to reflect total body fat mass and body lean mass index (LMI) to reflect total body lean mass (indirectly calculated through population formulas); high fat mass
corresponded to 3rd FMI sex-specific tertile and high lean mass corresponded to 3rd LMI sex-specific tertile while low fat mass corresponded to 1st merged with 2nd FMI sex-specific tertile and low lean mass corresponded to 1st
merged with 2nd LMI sex-specific tertile. Abbreviations: Hazard Ratio (HR), 95% Confidence Interval (95%CI). Bold indicates statistically significant outcomes i.e. p<0.05
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Table 5 C-index of multivariate models containing different anthropometric measurements to evaluate the discriminative ability against 10-year cardiovascular disease event in men and
women of the ATTICA (n=2,020) and GREECS study (n=2,172).
ATTICA study (Outcome: First fatal/non fatal cardiovascular disease event)

Men
Base model
Base model + BMI
Base model + FMI
Base model + LMI
Base model + body composition status
Women
Base model
Base model + BMI
Base model + FMI
Base model + LMI
Base model + body composition status

C-index (95%CI)

p-value

C-index changes (95%CI)

p-value

0.700 (0.678, 0.723)
0.705 (0.683, 0.728)
0.711 (0.689, 0.734)
0.731 (0.709, 0.753)
0.732 (0.711, 0.754)

<0.001
<0.001
<0.001
<0.001
<0.001

0.005 (-0.001, 0.007)
0.011 (0.008, 0.018)
0.031 (0.025, 0.039)
0.032 (0.026, 0.040)

0.12
0.01
0.001
0.001

0.751 (0.718, 0.784)
0.759 (0.728, 0.791)
0.774 (0.742, 0.806)
0.758 (0.725, 0.790)
0.774 (0.742, 0.806)

<0.001
<0.001
<0.001
<0.001
<0.001

0.008 (-0.003, 0.014)
0.017 (0.010, 0.025)
0.007 (-0.003, 0.009)
0.008 (-0.003, 0.014)

0.31
0.003
0.25
0.003

p-value

C-index changes (95%CI)

p-value

GREECS study (Outcome: Recurrent fatal/non fatal cardiovascular disease event)
C-index (95%CI)
Men
Base model

0.615 (0.578, 0.643)
<0.001
Base model + BMI
0.619 (0.580, 0.642)
<0.001
0.004 (-0.002, 0.007)
0.15
Base model + FMI
0.630 (0.586, 0.700)
<0.001
0.015 (0.006, 0.021)
0.04
Base model + LMI
0.620 (0.581, 0.643)
<0.001
0.005 (-0.003, 0.008)
0.10
Base model + body composition status
0.632 (0.587, 0.701)
<0.001
0.017 (0.008, 0.024)
0.05
Women
Base model
0.665 (0.618, 0.699)
<0.001
Base model + BMI
0.669 (0.620, 0.701)
<0.001
0.004 (-0.003, 0.005)
0.26
Base model + FMI
0.668 (0.619, 0.700)
<0.001
0.003 (-0.002, 0.005)
0.12
Base model + LMI
0.677 (0.627, 0.710)
<0.001
0.012 (0.007, 0.019)
0.002
Base model + body composition status
0.680 (0.671, 0.712)
<0.001
0.015 (0.010, 0.023)
0.002
Base model was adjusted for conventional cardiovascular disease risk factors i.e. age, hypercholesterolemia, diabetes mellitus, hypertension, currents smoking and family history of
cardiovascular disease. C-index and the corresponding confidence interval was evaluated through the area under the curve obtained from the Receiver operating Characteristics (ROC)
analysis. ROC analysis was performed using the probabilities for 10-year first fatal/non fatal cardiovascular disease event, corresponding to each study participant, separately for men and
women, calculated from Cox regression analysis using the multivariate models described. Significance of the changes in C-index was tested by differences in 2 log likelihood of regression
models with and without anthropometric measurements. FMI was created to reflect total body fat mass and LMI to reflect total body lean mass (indirectly calculated through population
formulas). Body composition status was defined as the combined lean and fat mass status as follows; high fat mass corresponded to 3rd FMI sex-specific tertile and high lean mass
corresponded to 3rd LMI sex-specific tertile while low fat mass corresponded to 1st merged with 2nd FMI sex-specific tertile and low lean mass corresponded to 1st merged with 2nd LMI
sex-specific tertile Abbreviations: body fat mass index (FMI), body mass index (BMI), body lean mass index (LMI), 95% Confidence Interval (95%CI).

1

14

